4D Pharma PLC
LSE:DDDD
4D Pharma PLC
LSE:DDDD
Price:
16.66 GBX
5.04%
Market Closed
Updated:
Jun 2, 2024
4D Pharma PLC
EPS (Diluted)
|
4D Pharma PLC
EPS (Diluted) Peer Comparison
Comparables:
GSK
AZN
INDV
HIK
DPH
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
4D Pharma PLC
LSE:DDDD
|
EPS (Diluted)
£0
|
CAGR 3-Years
4%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
EPS (Diluted)
£1
|
CAGR 3-Years
-6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
0%
|
|
|
AstraZeneca PLC
LSE:AZN
|
EPS (Diluted)
$4
|
CAGR 3-Years
10%
|
CAGR 5-Years
16%
|
CAGR 10-Years
10%
|
|
|
Indivior PLC
LSE:INDV
|
EPS (Diluted)
$0
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
EPS (Diluted)
$0
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-2%
|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
EPS (Diluted)
£0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is 4D Pharma PLC's EPS (Diluted)?
EPS (Diluted)
-0.3
GBP
-0.3
GBP
Based on the financial report for Dec 31, 2021, 4D Pharma PLC's EPS (Diluted) amounts to -0.3 GBP.
What is 4D Pharma PLC's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-16%
-16%
Over the last year, the EPS (Diluted) growth was -39%. The average annual EPS (Diluted) growth rates for 4D Pharma PLC have been 4% over the past three years , -16% over the past five years .
You don't have any saved screeners yet
